Dx Biosciences Garners $529,386 New Financing Round

  • Feed Type
  • Date
    3/7/2013
  • Company Name
    Dx Biosciences
  • Mailing Address
    10620 Treena St. San Diego, CA 92131
  • Company Description
    Develops novel, non-invasive diagnostic technologies to extract biomarkers from tissue samples.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $529,386
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.